Finance

Lists
Why is NVNO down 3.25%?
Dive Deeper
NVNO:NASDAQ
enVVeno Medical Corp
$8.04
-3.25%
(-0.27) 1D
$8.01
-0.37% (-0.030)
After hours
Closed: Oct 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVNO...
Open
$8.82
High
$9.41
Low
$8.01
Mkt. cap
5.49M
Avg. vol.
25.31K
Volume
25.19K
52-wk high
$35.18
52-wk low
$7.01
EPS
-$25.19
Beta
1.06
Shares outstanding
695.00K
No. of employees
33
Open
$8.82
High
$9.41
Low
$8.01
Mkt. cap
5.49M
Avg. vol.
25.31K
Volume
25.19K
52-wk high
$35.18
52-wk low
$7.01
EPS
-$25.19
Beta
1.06
Shares outstanding
695.00K
No. of employees
33
News stories
From web sources and news partners
About enVVeno Medical Corp
CEO-
Employees33
Founded1999
HeadquartersIrvine, California, United States
SectorMedical device
Websiteenvveno.com
Analyst ratings
Based on 1 analyst giving stock ratings to NVNO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NVNO in the last 3 months
Highest
Current $8.04
$30.00 (+273.13%)
Average
$30.00 (+273.13%)
Lowest
$30.00 (+273.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Upgraded
$30.00
+273.1%
07/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.58M
1.95M
2.11M
2.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.59M
2.40M
1.95M
1.72M
Operating expense
5.17M
4.35M
4.06M
3.80M
Total operating expenses
5.17M
4.35M
4.06M
3.80M
Operating income
-5.17M
-4.35M
-4.06M
-3.80M
Other non operating income
-
-
-
-
EBT including unusual items
-4.54M
-3.74M
-3.85M
-3.60M
EBT excluding unusual items
-5.00M
-4.24M
-4.04M
-3.79M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.54M
-3.74M
-3.85M
-3.60M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-5.37
Interest and investment income
175.00K
103.00K
22.00K
9.00K
Interest expense
-
-
-
-
Net interest expenses
175.00K
103.00K
22.00K
9.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.14M
-4.32M
-4.03M
-3.76M
Gain or loss from assets sale
-
-
4.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps